Richard Jefferson

Article Abstract:

Geneticist Richard Jefferson is one of many in this global grass roots movement to create a framework for scientists to develop biotechnologies unimpeded by patents, licenses and lawyers. Jefferson moved to Wageningen in the Netherlands to establish CAMBIA (the Center for Application of Molecular Biology to International Agriculture) a not-for-profit research organization for distributing plant biotech research tools.

Biography, Geneticists, Personality profile, Jefferson, Richard

---

Struggling to see the forest through the trees

Article Abstract:

The anti-GMO protest broke on December 2004 in Argentina at the tenth anniversary of United Nations (UN) conference on climate change. The protestors disagreed about the genetically modified (GM) trees, which are considered a viable, clean mechanism under the Kyoto Protocol for sequestering carbons in the environment, which contribute to global warming.

Conferences, meetings and seminars, Environmental aspects, United Nations, Climatic changes, Climate change, Genetically modified crops

---

Jim Greenwood

Article Abstract:

The personality, life and achievements of Jim Greenwood are detailed. He is a fervent supporter of embryonic stem cell research and a dogged opponent of corporate wrongdoers, and is a US congressman who is stepping out of politics to head biotech's biggest industry organization.

Appreciation, Works, Legislators, Congressional representatives, Greenwood, Jim

Similar abstracts:

• Abstracts: Dining out on the future. The 'green' CV. Boards needs more chartered accountants
• Abstracts: India aims to become the main bioinformatics hub. Off the beaten path. E&Y report backs Asia-Pacific biotech
• Abstracts: Further cuts may loom in Navy shipbuilding request. . Costs loom for Northrop, others in storm damage. Northrop Ship Systems yard braced for hurricane
• Abstracts: Touchy-feeling: A marketing scheme highlights the sensual qualities of materials. Matter of course
• Abstracts: When will Israeli biotech grow up?. First inhalable insulin approved. Dow pulls out of bioplastics due to slow sector maturation

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.